Similar articles

• Calcineurin inhibition in severe ulcerative colitis: lost in translation?

  Annunziata ML, Hanauer SB. Annunziata ML, et al. Inflamm Bowel Dis. 2012 May;18(5):809-11. doi: 10.1002/ibd.21848. Epub 2011 Aug 11. Inflamm Bowel Dis. 2012. PMID: 21837776 No abstract available.
• Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.

  Ogata H, Kato J, Hirai F, Hida N, Matsui T, Matsumoto T, Koyanagi K, Hibi T. Ogata H, et al. Inflamm Bowel Dis. 2012 May;18(5):803-8. doi: 10.1002/ibd.21853. Epub 2011 Sep 1. Inflamm Bowel Dis. 2012. PMID: 21887732 Clinical Trial.
• Response to Roblin and Del Tedesco.

  Ogata H. Ogata H. Inflamm Bowel Dis. 2013 Apr;19(5):E68. doi: 10.1097/MIB.0b013e318281015f. Inflamm Bowel Dis. 2013. PMID: 23538853 No abstract available.
• Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.

  Farkas K, Molnár T, Szepes Z. Farkas K, et al. Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):695-702. doi: 10.1586/17474124.2014.909726. Epub 2014 Apr 17. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24738535 Review.
• Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.

  Wu B, Tong J, Ran Z. Wu B, et al. Inflamm Bowel Dis. 2020 Jan 1;26(1):24-32. doi: 10.1093/ibd/izz068. Inflamm Bowel Dis. 2020. PMID: 30980713 Review.